These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23175860)

  • 1. Should you skip your PSA test? The science is uncertain for now, so arm yourself with deep knowledge of the pros and cons of prostate cancer screening.
    Harv Mens Health Watch; 2012 Oct; 17(3):1, 7. PubMed ID: 23175860
    [No Abstract]   [Full Text] [Related]  

  • 2. Your PSA test result: what's next? If the test result hints at cancer, your doctor will need to rule out noncancerous causes and may perform additional tests.
    Harv Mens Health Watch; 2012 Dec; 17(5):4-5. PubMed ID: 23373112
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should you get a PSA test? The latest thinking on this controversial screening.
    Harv Health Lett; 2013 Jan; 38(3):5. PubMed ID: 23556164
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen: a new(ish) study.
    Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
    [No Abstract]   [Full Text] [Related]  

  • 8. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific antigen.
    Brett T
    Aust Fam Physician; 2011 Jul; 40(7):497-500. PubMed ID: 21743854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 12. Active surveillance: an option for low-risk prostate cancer. For some men, the smartest move after diagnosis may be to delay treatment and carefully watch the progression of the cancer.
    Harv Mens Health Watch; 2013 Mar; 17(8):4-5. PubMed ID: 23807955
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA approves new PSA test.
    Harv Mens Health Watch; 2012 Sep; 17(2):8. PubMed ID: 23050286
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of knowledge regarding prostate-specific antigen screening: is ignorance bliss?
    Hahn DL
    J Fam Pract; 1999 Sep; 48(9):679-81. PubMed ID: 10498073
    [No Abstract]   [Full Text] [Related]  

  • 15. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening practice and knowledge in Rhode Island.
    Glicksman AS; Meyer A; Cullinen K
    Med Health R I; 2009 Feb; 92(2):65-6. PubMed ID: 19288690
    [No Abstract]   [Full Text] [Related]  

  • 17. Two randomized screening trials with prostate cancer mortality, two interim results: a consideration of usual-care window in screening trials.
    Song Y
    Contemp Clin Trials; 2010 Jul; 31(4):378-80. PubMed ID: 20450987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for prostate cancer: prostate-specific antigen testing is not effective.
    Hitzeman N; Molina M
    Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighing in on the great PSA debate.
    Johns Hopkins Med Lett Health After 50; 2002 Jul; 14(5):6. PubMed ID: 12154801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.